methylene blue has been researched along with Liver Steatosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YH; Kim, SG; Kim, TH; Shin, SY; Wu, H | 1 |
Haym, J; Schmidt, D | 1 |
2 other study(ies) available for methylene blue and Liver Steatosis
Article | Year |
---|---|
SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.
Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Repositioning; Energy Metabolism; Enzyme Activation; Enzyme Activators; Fatty Liver; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Methylene Blue; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Turnover; NAD; Rats; RNA Interference; Sirtuin 1; Time Factors; Transfection | 2014 |
[On the problem of a selective thermosensitization of carcinoma cells in vivo with vitamin K3-sodium bisulfite, methylene blue and other thermosensitizators. 1. On the toxicology of vitamin K3-sodium bisulfite in combination with methylene blue on rats an
Topics: Animals; Carcinoma, Ehrlich Tumor; Dogs; Fatty Liver; Female; Fever; Hemorrhage; Male; Methylene Blue; Mice; Necrosis; Nephrosis; Rats; Sodium; Species Specificity; Sulfites; Vitamin K | 1968 |